Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.37 |
| ▸ | RAB9A | P51151 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CASP3 | P42574 | 1/20 | 0.36 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.36 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.36 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNA5 | P30532 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23911674 | 0.77 | NOTUM (0.55) | NOTUMNPC1RAB9ALMNACASP3 | |
| SCHEMBL6003977 | 0.66 | RECQL (0.58) | NOTUMRECQL | |
| SCHEMBL24061386 | 0.66 | NOTUM (0.66) | NOTUMNPC1RAB9ACASP3SENP8 | |
| SCHEMBL24800050 | 0.64 | HDAC1 (0.46) | NOTUMNPC1RECQL | |
| SCHEMBL30216060 | 0.63 | KDM1A (0.38) | — | |
| SCHEMBL1494553 | 0.63 | KDM1A (0.38) | — | |
| SCHEMBL18977807 | 0.62 | NOTUM (0.66) | NOTUMNPC1RAB9ACASP3SENP8 | |
| SCHEMBL31097867 | 0.61 | ALDH1A1 (0.38) | LMNAL3MBTL1 | |
| SCHEMBL3407155 | 0.61 | NOTUM (1.00) | NOTUMNPC1RAB9ACASP3SENP8 | |
| SCHEMBL2768635 | 0.61 | NOTUM (0.70) | NOTUMNPC1RAB9ALMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210317112-A1 | HETEROCYCLIC COMPOUNDS AS PESTICIDES | BAYER AG (DE) | 2021-10-14 | — | — | US | disclosed |
| US-20210317112-A1 | HETEROCYCLIC COMPOUNDS AS PESTICIDES | BAYER AG (DE) | 2021-10-14 | — | — | US | disclosed |
| CN-111601802-A | Heterocyclic compounds as pesticides | 拜耳股份有限公司 | 2020-08-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317112-A1 | HETEROCYCLIC COMPOUNDS AS PESTICIDES | DDT, ACHE, PTMS | NOTUM 308/4885NPC1 3224/4885RAB9A 1676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.